NORTH AMERICAN SCIENCE ASSOCIATES LIMITED

NORTH AMERICAN SCIENCE ASSOCIATES LIMITED

Company Registration Number:
03494969 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2022

Period of accounts

Start date: 1 January 2022

End date: 31 December 2022

NORTH AMERICAN SCIENCE ASSOCIATES LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2022

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

NORTH AMERICAN SCIENCE ASSOCIATES LIMITED

Directors' report period ended 31 December 2022

The directors present their report with the financial statements of the company for the period ended 31 December 2022

Additional information

Directors' responsibilities statementGoing concernAuditor



Directors

The director shown below has held office during the period of
1 January 2022 to 9 February 2022

Michael Brookman


The director shown below has held office during the period of
9 February 2022 to 31 December 2022

Matthew Micowski


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
6 September 2023

And signed on behalf of the board by:
Name: Matthew Micowski
Status: Director

NORTH AMERICAN SCIENCE ASSOCIATES LIMITED

Profit And Loss Account

for the Period Ended 31 December 2022

2022 14 months to 31 December 2021


£

£
Turnover: 5,693,408 5,137,738
Cost of sales: ( 4,822,524 ) ( 4,839,178 )
Gross profit(or loss): 870,884 298,560
Administrative expenses: ( 881,331 ) ( 804,034 )
Operating profit(or loss): (10,447) (505,474)
Profit(or loss) before tax: (10,447) (505,474)
Tax: ( 84,370 ) 19,624
Profit(or loss) for the financial year: (94,817) (485,850)

NORTH AMERICAN SCIENCE ASSOCIATES LIMITED

Balance sheet

As at 31 December 2022

Notes 2022 14 months to 31 December 2021


£

£
Fixed assets
Intangible assets: 3 0 3,334
Tangible assets: 4 123,387 130,898
Total fixed assets: 123,387 134,232
Current assets
Debtors: 5 5,801,022 3,812,936
Cash at bank and in hand: 319,069 1,200,769
Total current assets: 6,120,091 5,013,705
Creditors: amounts falling due within one year: 6 ( 5,104,013 ) ( 3,913,655 )
Net current assets (liabilities): 1,016,078 1,100,050
Total assets less current liabilities: 1,139,465 1,234,282
Total net assets (liabilities): 1,139,465 1,234,282
Capital and reserves
Called up share capital: 990 990
Share premium account: 4,430 4,430
Profit and loss account: 1,134,045 1,228,862
Total Shareholders' funds: 1,139,465 1,234,282

The notes form part of these financial statements

NORTH AMERICAN SCIENCE ASSOCIATES LIMITED

Balance sheet statements

For the year ending 31 December 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 6 September 2023
and signed on behalf of the board by:

Name: Matthew Micowski
Status: Director

The notes form part of these financial statements

NORTH AMERICAN SCIENCE ASSOCIATES LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Revenue is recognised to the extent that it is probable that the economic benefits will flow to thecompany and the revenue can be reliably measured. Revenue is measured as the fair value of theconsideration received or receivable, excluding discounts, rebates, value added tax and other salestaxes. The following criteria must also be met before revenue is recognised:Rendering of servicesRevenue from a contract to provide services is recognised in the period in which the services areprovided in accordance with the stage of completion of the contract when all of the followingconditions are satisfiedthe amount of revenue can be measured reliably;it is probable that the company will receive the consideration due under the contract;the stage of completion of the contract at the end of the reporting period can be measuredreliably; andthe costs incurred and the costs to complete the contract can be measured reliably.

    Tangible fixed assets depreciation policy

    Tangible fixed assets under the cost model are stated at historical cost less accumulateddepreciation and any accumulated impairment losses. Historical cost includes expenditure that isdirectly attributable to bringing the asset to the location and condition necessary for it to be capable ofoperating in the manner intended by management

    Intangible fixed assets amortisation policy

    Intangible assets are initially recognised at cost. After recognition, under the cost model, intangibleassets are measured at cost less any accumulated amortisation and any accumulated impairmentlosses.All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful lifecannot be made, the useful life shall not exceed ten years.The estimated useful lives range as follows:Other intangible fixed assets - 10% straight line

    Other accounting policies

    DebtorsCash and cash equivalentsCreditorsForeign currency translationLong-term contractsFinance costsOperating leases: the company as lesseePensionsInterest incomeProvisions for liabilitiesCurrent and deferred taxation

NORTH AMERICAN SCIENCE ASSOCIATES LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

  • 2. Employees

    2022 14 months to 31 December 2021
    Average number of employees during the period 43 43

NORTH AMERICAN SCIENCE ASSOCIATES LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

3. Intangible assets

Goodwill Other Total
Cost £ £ £
At 1 January 2022 10,000 10,000
Additions
Disposals
Revaluations
Transfers
At 31 December 2022 10,000 10,000
Amortisation
At 1 January 2022 6,666 6,666
Charge for year 3,334 3,334
On disposals
Other adjustments
At 31 December 2022 10,000 10,000
Net book value
At 31 December 2022 0 0
At 31 December 2021 3,334 3,334

NORTH AMERICAN SCIENCE ASSOCIATES LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

4. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 January 2022 283,319 125,493 408,812
Additions
Disposals
Revaluations
Transfers
At 31 December 2022 283,319 125,493 408,812
Depreciation
At 1 January 2022 152,421 125,493 277,914
Charge for year 7,511 7,511
On disposals
Other adjustments
At 31 December 2022 159,932 125,493 285,425
Net book value
At 31 December 2022 123,387 0 123,387
At 31 December 2021 130,898 0 130,898

NORTH AMERICAN SCIENCE ASSOCIATES LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

5. Debtors

2022 14 months to 31 December 2021
£ £
Trade debtors 1,033,570 655,371
Prepayments and accrued income 467,276 424,273
Other debtors 4,300,176 2,733,292
Total 5,801,022 3,812,936

NORTH AMERICAN SCIENCE ASSOCIATES LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

6. Creditors: amounts falling due within one year note

2022 14 months to 31 December 2021
£ £
Trade creditors 304,973 118,298
Taxation and social security 259,972 1,070,583
Accruals and deferred income 1,684,796 787,156
Other creditors 2,854,272 1,937,618
Total 5,104,013 3,913,655